- Stocks
- Pharma & Healthcare
- Sunil Health
Sunil Health share price
NSE: SUNLOCPharma & HealthcareDrug Manufacturers - Specialty & Generic
Sunil Health at a glance
Sunil Health (NSE: SUNLOC) closed at ₹65.00 on 21 Oct 2026. With a market capitalisation of ₹67 Cr, it ranks 2908th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
At its last close the stock traded at 16.6× trailing earnings, against a return on equity of 5.8% in FY26. Its 52-week range is ₹63.21 (21 Oct 2026) to ₹82.00 (1 Sep 2026); the last close is 20.7% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹20 Cr (−7.0% year on year) and net profit ₹2 Cr (+322.2%), on a consolidated basis. Promoters held 73.53% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹67 CrRank 2908 on NSE
- P/E (trailing)
- 16.6×
- Price to book
- 0.91×FY26
- EPS (TTM)
- ₹3.91to Q4 FY26
- ROE
- 5.8%FY26
- ROCE
- 8.7%FY26
- Debt to equity
- 0.8FY26
- Net profit margin
- 4.6%FY26
- Book value / share
- ₹67.87FY26
- 52-week high
- ₹82.001 Sep 2026
- 52-week low
- ₹63.2121 Oct 2026
- RSI (14-day)
- 43
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | 0.00% | −0.8% | −11.6% | — | — |
Sunil Health quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹22 Cr | ₹20 Cr | ₹20 Cr | ₹21 Cr | ₹23 Cr | ₹24 Cr | ₹22 Cr | ₹20 Cr |
| Revenue YoY | −4.5% | −14.5% | −9.7% | −0.5% | +5.3% | +16.1% | +6.7% | −7.0% |
| Net profit | −₹1 Cr | −₹1 Cr | −₹1 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Net profit YoY | — | — | — | +140.0% | — | — | — | +322.2% |
| Net margin | −3.2% | −2.7% | −2.6% | 1.7% | 4.0% | 4.3% | 2.7% | 7.7% |
| EPS | −₹0.67 | −₹0.53 | −₹0.53 | ₹0.35 | ₹0.89 | ₹0.97 | ₹0.57 | ₹1.48 |
Sunil Health financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹90 Cr | ₹119 Cr | ₹110 Cr | ₹90 Cr | ₹83 Cr | — |
| Operating profit | −₹1 Cr | ₹9 Cr | ₹9 Cr | −₹3 Cr | −₹1 Cr | — |
| Net profit | −₹1 Cr | ₹6 Cr | ₹7 Cr | −₹2 Cr | −₹1 Cr | — |
| EPS (₹) | −₹1.00 | ₹6.00 | ₹7.00 | −₹2.00 | −₹1.00 | — |
| Cash from operations | ₹17 Cr | ₹23 Cr | ₹7 Cr | −₹15 Cr | ₹12 Cr | — |
| Total debt | ₹15 Cr | ₹11 Cr | ₹8 Cr | ₹19 Cr | ₹18 Cr | ₹16 Cr |
| Shareholders' equity | ₹44 Cr | ₹50 Cr | ₹57 Cr | ₹70 Cr | ₹69 Cr | ₹70 Cr |
Sunil Health shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% | 73.53% |
| Domestic institutions | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% | 0.10% |
| Non-institutions | 26.37% | 26.37% | 26.37% | 26.37% | 26.37% | 26.37% |
Sunil Health vs peers
The listed Pharma & Healthcare companies nearest to Sunil Health by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| SOURCENTRLSource Natural | — | — | — | ₹70 Cr | — | — |
| APLAsston Pharma | — | — | — | ₹69 Cr | — | — |
| FERVENTSYNFervent Synergi | — | — | — | ₹68 Cr | — | — |
| SUNLOCSunil Health | ₹65.00 | 0.00% | — | ₹67 Cr | 16.6 | — |
| SAMRATPHSamrat Pharma | — | — | — | ₹61 Cr | — | — |
| ROYALRoyal Sense | — | — | — | ₹59 Cr | — | — |
| BACPHARBacil Pharma | — | — | — | ₹58 Cr | — | — |
Ask anything about Sunil Health
Pivot answers on the live chart with evidence you can check, and tests strategies against SUNLOC's own history. Try: “Why has SUNLOC moved over the last three months?” · “Backtest a 50-day moving-average crossover on SUNLOC over five years” · “Compare SUNLOC with SOURCENTRL on margins and valuation”
Frequently asked questions about Sunil Health
What is the share price of Sunil Health today?
Sunil Health (NSE: SUNLOC) last closed at ₹65.00 on 21 Oct 2026. Its 52-week high is ₹82.00 and its 52-week low is ₹63.21.
What is the market cap of Sunil Health?
Sunil Health's market capitalisation is ₹67 Cr (₹67 Cr) at the 22 Oct 2026 close, ranking 2908th among the NSE companies Pivot tracks.
What is the P/E ratio of Sunil Health?
Sunil Health trades at a trailing P/E of 16.6.
What is the ROE and ROCE of Sunil Health?
Return on equity was 5.8% in FY26 and return on capital employed was 8.7% in FY26 (consolidated figures).
Is Sunil Health a debt-free company?
No. Sunil Health's debt-to-equity ratio was 0.8 in FY26, with total debt of ₹16 Cr.
What were Sunil Health's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Sunil Health reported revenue of ₹20 Cr, −7.0% year on year, and net profit of ₹2 Cr, +322.2% year on year.
What is the shareholding pattern of Sunil Health?
As of 30 Jun 2026: promoters 73.53%, domestic institutions 0.10%, non-institutions 26.37%.
Who are Sunil Health's competitors?
The listed Pharma & Healthcare companies closest to Sunil Health by market cap are Source Natural, Asston Pharma, Fervent Synergi, Samrat Pharma, Royal Sense and Bacil Pharma.
Is Sunil Health a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Sunil Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SUNLOC against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 21 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with S · all NSE stocks · this page as text